NIKKEI 225
37,982.28 -832.28 (-2.14%) HANG SENG
17,978.30 +36.52 (+0.20%) CRUDE OIL
78.17 -0.28 (-0.36%) GOLD FUTURES
2,338.30 -10.80 (-0.46%) DOW
38,589.16 -57.94 (-0.15%) Bitcoin GBP
52,352.63 +216.21 (+0.41%)
RAPT Oct 2024 10.000 put
| Previous close | 4.1000 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 10.00 |
| Expiry date | 2024-10-18 |
| Day's range | 4.1000 - 4.1000 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksDown -15.94% in 4 Weeks, Here's Why Rapt Therapeutics (RAPT) Looks Ripe for a Turnaround
Rapt Therapeutics (RAPT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksRapt Therapeutics (RAPT) Loses -47.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Rapt Therapeutics (RAPT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ZacksHere's Why Rapt Therapeutics (RAPT) is Poised for a Turnaround After Losing -52.88% in 4 Weeks
The heavy selling pressure might have exhausted for Rapt Therapeutics (RAPT) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
